CLARENTIS® Technologies
The Global Standard in Hypochlorous Acid Technology
Clarentis® Technologies LLC provides an asset-light, highly scalable, and fully validated electrochemical activation (ECA) platform driven by industry-leading, high-performance electrolytic cells. We collaborate through strategic corporate partnerships and commercial alignments with United States enterprise leaders, government agencies, and sovereign entities to deploy eco-friendly food safety systems, hospitality hygiene, and large-scale public health solutions backed by extensive federal regulatory approvals.
Enterprise Value & Technology Assets
- High-Performance Electrolytic Engineering: Powered by ultra-durable, premium-engineered electrolytic cells designed for maximum operational efficiency with consistent chemical output. This high-quality hardware ensures precise control over the activation process, delivering uncompromised reliability and low maintenance overhead for high-capacity applications.
- Biofilm Eradication & Water Infrastructure Protection: Peer-reviewed verification and publication in the Journal of Hospital Infection validate the system's absolute capability to safely disinfect water infrastructure and eradicate complex biofilms. Four published studies confirm the technology's effectiveness in providing automated, large-scale infection control and preventing the trafficking of antimicrobial-resistant pathogens.
- Food Safety & Agriculture (FDA): Fully approved under FCN 2188 and FCN 2316 for highly scalable on-site manufacturing and use of Ultra-Lyte® (up to 60 ppm FAC) in processing meat, poultry, seafood, produce, and shell eggs. The 6-month shelf life under FCN 2316 entirely removes secondary washing steps, preserving thousands of gallons of clean water daily, eliminating accidental chemical carryover, and slashing operational timelines.
- Healthcare & Hospitality Protection (EPA): EPA Reg. No. 86854-1 registers Ultra-Lyte® as a medical hospital disinfectant with authorized efficacy claims against high-stakes pathogens like Clostridium difficile (C. diff) and Candida auris. This delivers medical-grade infection control to healthcare facilities, commercial hospitality networks, hotels, and cruise lines to protect dense guest environments.Â
- Government & Sovereign Applications: Offers critical infrastructure protection, military logistics readiness, and national-level biosafety compliance. The highly scalable platform provides sovereign entities with automated, self-sustaining biosecurity assets capable of protecting public water infrastructure, strategic food supplies, and civil emergency response networks without relying on vulnerable chemical supply chains.
